Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcu...
Q2 2026
Aug 5, 2026
Q1 2026
May 13, 2026
FY 2025
Mar 23, 2026
Q4 2025
Q3 2025
Nov 13, 2025
